<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05054335</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0216</org_study_id>
    <secondary_id>NCI-2019-00862</secondary_id>
    <secondary_id>2018-0216</secondary_id>
    <nct_id>NCT05054335</nct_id>
  </id_info>
  <brief_title>Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas</brief_title>
  <official_title>CPRIT: Optimizing Surgical and Rehabilitation Treatment of Pelvic Sarcomas Using Computational Models</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies the development of patient-specific computational walking models to&#xD;
      improve the surgical planning and rehabilitation treatment of patients with pelvic sarcomas.&#xD;
      Every pelvis and pelvic sarcoma are different, and the orthopedic oncologist faces&#xD;
      significant challenges when removing a tumor from the complex anatomy of the pelvis. These&#xD;
      challenges make it difficult to achieve excellent oncological and functional outcomes&#xD;
      together. Computational walking models may be used to predict the best combination of&#xD;
      surgical methods and how to implement them to maximize each patient's post-surgery walking&#xD;
      function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To develop patient-specific computational walking models to predict the optimal&#xD;
      combination of pelvic sarcoma surgical and rehabilitation decisions that will maximize each&#xD;
      patient's post-surgery walking function.&#xD;
&#xD;
      II. To collect experimental movement and imaging data prospectively and retrospectively from&#xD;
      individuals who have already received, or are going to receive, a type I or type II&#xD;
      hemipelvectomy.&#xD;
&#xD;
      III. To use the data to develop computational modeling and simulation methodologies that can&#xD;
      predict an individual patient's post-surgery walking function given pre-surgery movement and&#xD;
      imaging data and the surgical decisions made by the surgeon.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients undergo walking function assessment using optical motion capture and bi-plane&#xD;
      dynamic X-ray imaging pre- and post-hemipelvectomy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 20, 2019</start_date>
  <completion_date type="Anticipated">May 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To establish the patient-specific computational models to inform surgical decisions and design custom implants that maximize post-surgery function.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Pelvic Sarcoma</condition>
  <arm_group>
    <arm_group_label>Supportive care (walking function test, X-ray)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo walking function assessment using optical motion capture and bi-plane dynamic X-ray imaging pre- and post-hemipelvectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Functional Assessment</intervention_name>
    <description>Undergo walking function assessment with optical motion capture</description>
    <arm_group_label>Supportive care (walking function test, X-ray)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>X-Ray Imaging</intervention_name>
    <description>Undergo bi-plane dynamic X-ray imaging</description>
    <arm_group_label>Supportive care (walking function test, X-ray)</arm_group_label>
    <other_name>Conventional X-Ray</other_name>
    <other_name>Diagnostic Radiology</other_name>
    <other_name>Medical Imaging, X-Ray</other_name>
    <other_name>Radiography</other_name>
    <other_name>Static X-Ray</other_name>
    <other_name>X-Ray</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have received or are scheduled to receive a type II or any combination of&#xD;
             type II (e.g., type I + II, II + III, or I + II + III) hemipelvectomy surgery without&#xD;
             reconstruction or with allograft reconstruction at University of Texas (UT) MD&#xD;
             Anderson Cancer Center.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients whose leg has been or will be amputated by hemipelvectomy surgery.&#xD;
&#xD;
          -  Previous surgery or significant injury to either hip.&#xD;
&#xD;
          -  Relevant surgery, procedure, injury, or condition in the last two years which may&#xD;
             affect hip pain or general movement patterns on either side.&#xD;
&#xD;
          -  Diagnosis of osteoarthritis, rheumatoid conditions, cancers, or other conditions which&#xD;
             may affect musculoskeletal health.&#xD;
&#xD;
          -  Pregnant women or women nursing an infant.&#xD;
&#xD;
          -  Persons with body mass index (BMI) &gt; 30 and/or waist size &gt; 100 cm (39 in) (these&#xD;
             individuals would likely require higher radiation doses than are specified for this&#xD;
             study).&#xD;
&#xD;
          -  Persons with a history of significant radiation exposure (greater than 25 mSv),&#xD;
             whether occupational or medical in nature. Anyone with a history of medical radiation&#xD;
             therapy (for cancer or other conditions) is excluded from the study.&#xD;
&#xD;
          -  Persons with a pacemaker, hearing aid, aneurysm clips or artificial heart valves, and&#xD;
             other forms of loose metal implants will be excluded from the study as assessed by a&#xD;
             pre-magnetic resonance imaging (MRI) questionnaire administered by the MRI technician&#xD;
             at the time of the scan.&#xD;
&#xD;
          -  Radiological exclusion criteria (assessed after magnetic resonance [MR] scan is&#xD;
             conducted on the first visit, prior to dynamic stereo X-ray [DSX]/computed tomography&#xD;
             [CT] radiation exposure): evidence on preliminary MRI of avascular necrosis (AVN),&#xD;
             fracture, slipped capital femoral epiphysis (SCFE), collapsed joint space or advanced&#xD;
             osteoarthritis, hip dysplasia, masses, lesions, or other anomalies not consistent with&#xD;
             a femoro-acetabular impingement (FAI) diagnosis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valerae O Lewis</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerae O. Lewis</last_name>
      <phone>713-745-4117</phone>
      <email>volewis@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Valerae O. Lewis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>M D Anderson Cancer Center</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 7, 2019</study_first_submitted>
  <study_first_submitted_qc>September 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2021</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

